Zydus Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

8,731.60

7,981.90

7,790.40

6,347.40

6,037.40

Operating profit

2,454.40

1,918.10

2,319.10

1,423.10

1,629.80

Interest

278.20

134.90

70.90

233.90

89.60

Gross profit

2,724.60

1,961.90

2,327.10

2,038.60

2,099.50

EPS (Rs)

15.11

8.38

14.42

13.80

14.51

Other income

548.40

178.70

78.90

849.40

559.30

Stock adjustment

105.10

-46.90

-148.30

15.50

-86.00

Raw material

2,703.50

2,629.00

2,346.40

1,838.30

1,755.80

Power and fuel

-

-

-

-

-

Employee expenses

1,321.90

1,204.90

1,147.30

1,077.40

961.20

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2,146.70

2,276.80

2,125.90

1,993.10

1,776.60

Provisions made

-

-

-

-

-

Depreciation

488.60

478.70

451.10

428.90

358.20

Taxation

503.00

306.00

212.30

204.10

301.50

Net profit / loss

1,529.20

857.90

1,476.20

1,412.90

1,485.70

Extra ordinary item

-203.80

-319.30

-187.50

7.30

45.90

Prior year adjustments

-

-

-

-

-

Equity capital

101.20

102.40

102.40

102.40

102.40

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.11

24.03

29.77

22.42

27.00

GPM (%)

29.36

24.04

29.57

28.33

31.83

NPM (%)

16.48

10.51

18.76

19.63

22.52